MAPS Canada School of Psychedelics

Talk abstract

Early-stage research on psychedelic interventions for psychological suffering associated with the end of life is highly diverse. Sociocultural factors shape both the methods, interventional approaches used, and the explanations applied to each substance. Ketamine was mainly linked to the biomedical model, unlike other substances. Outcome measures spanned biopsychosocial-spiritual domains. The therapeutic value of challenging experiences remains uncertain. Exploring treatment diversity is essential, but greater standardisation in reporting would enhance the rigor of future research.